100 mg powder for solution for infusion
- Tumor necrosis factor alpha (TNF-α) inhibitors.
- Chimeric human-murine monoclonal antibody to selectively block both soluble and transmembrane forms of tumor necrosis factor (TNF-α).
- INFLIMAB used to treat a wide range of severe autoimmune diseases: rheumatoid and psoriatic arthritis, ankylosing spondylitis, Crohn’s disease (active form), ulcerative colitis and psoriasis. It is usually used when other medicines or treatments have failed.
- INFLIMAB® is the first biosimilar of Remicade® in Belarus with the identity efficacy and safety profile proven in comparative clinical studies.